Marica Eoli

机构：Fondazione IRCCS Istituto Neurologico Carlo Besta · ORCID：0000-0003-4744-9377

发表论文 396 篇 · 总被引 12739 次 · h-index 44

代表论文

• Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study (2025 · The Lancet · 被引 52)
• Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection—Update 1 (2024 · Neuro-Oncology · 被引 29)
• Polyclonal expansion of functional tumor-reactive lymphocytes infiltrating glioblastoma for personalized cell therapy (2025 · Nature Communications · 被引 5)
• Response assessment of GBM during immunotherapy by delayed contrast treatment response assessment maps (2024 · Frontiers in Neurology · 被引 5)
• Genetic Engineering of Hematopoietic Progenitor Stem Cells for Targeted IFN-α Immunotherapy Reprogramming the Solid Tumor Microenvironment: A First-in-Man Study in Glioblastoma Multiforme (NCT03866109) (2023 · Blood · 被引 4)
• STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma (2025 · Journal of Clinical Oncology · 被引 3)